These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6172017)

  • 1. Structure-activity relationships in the actions of 1-phenyl-piperazines on brain serotonin receptors.
    Fuller RW; Mason NR
    Adv Exp Med Biol; 1981; 133():359-68. PubMed ID: 6172017
    [No Abstract]   [Full Text] [Related]  

  • 2. 1-(1-Naphthyl)piperazine, a central serotonin agonist.
    Fuller RW; Mason NR; Snoddy HD; Perry KW
    Res Commun Chem Pathol Pharmacol; 1986 Jan; 51(1):37-45. PubMed ID: 2419952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition and pharmacological effects of m-Chlorophenylpiperazine in rats.
    Fuller RW; Snoddy HD; Mason NR; Owen JE
    Neuropharmacology; 1981 Feb; 20(2):155-62. PubMed ID: 6163105
    [No Abstract]   [Full Text] [Related]  

  • 4. [Serotonin and D-lysergic acid diethylamide receptors in the mammalian brain].
    Vlasova TI; Kirzon MV
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1981; (5):5-16. PubMed ID: 6264979
    [No Abstract]   [Full Text] [Related]  

  • 5. Brain serotonin receptors and neuropsychiatric disorders.
    Enna SJ
    Adv Exp Med Biol; 1981; 133():347-57. PubMed ID: 6274171
    [No Abstract]   [Full Text] [Related]  

  • 6. 6-substituted 1,3,4,5-tetrahydrobenz[cd]indol-4-amines: potent serotonin agonists.
    Flaugh ME; Mullen DL; Fuller RW; Mason NR
    J Med Chem; 1988 Sep; 31(9):1746-53. PubMed ID: 2457705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A detailed protocol for the in vitro radioautographic visualization of serotonergic receptors.
    Meibach RC
    J Histochem Cytochem; 1982 Aug; 30(8):831-6. PubMed ID: 7119426
    [No Abstract]   [Full Text] [Related]  

  • 8. Substituted piperazines as central serotonin agonists: comparative specificity of the postsynaptic actions of quipazine and m-trifluoromethylphenylpiperazine.
    Fuller RW; Snoddy HD; Mason NR; Hemrick-Luecke SK; Clemens JA
    J Pharmacol Exp Ther; 1981 Sep; 218(3):636-41. PubMed ID: 6167711
    [No Abstract]   [Full Text] [Related]  

  • 9. A possible role of serotonin receptors in antidepressant drug action.
    Snyder SH; Peroutka SJ
    Pharmacopsychiatria; 1982 Jul; 15(4):131-4. PubMed ID: 7146092
    [No Abstract]   [Full Text] [Related]  

  • 10. The influence of quipazine on the turnover rate of serotonin.
    Grabowska M; Antkiewicz L; Michaluk J
    Biochem Pharmacol; 1974 Nov; 23(22):3211-2. PubMed ID: 4441411
    [No Abstract]   [Full Text] [Related]  

  • 11. Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol.
    Peroutka SJ; Snyder SH
    Mol Pharmacol; 1979 Nov; 16(3):687-99. PubMed ID: 530254
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute changes in central serotonin metabolism induced by the blockade or stimulation of serotoninergic receptors during ontogenesis in the rat.
    Bourgoin S; Artaud F; Enjalbert A; Héry F; Glowinski J; Hamon M
    J Pharmacol Exp Ther; 1977 Sep; 202(3):519-31. PubMed ID: 894519
    [No Abstract]   [Full Text] [Related]  

  • 13. Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors.
    Bennett JP; Snyder SH
    Mol Pharmacol; 1976 May; 12(3):373-89. PubMed ID: 6896
    [No Abstract]   [Full Text] [Related]  

  • 14. Measurement of serotonin receptors in post-mortem human brain.
    Whitaker PM
    J Histochem Cytochem; 1982 Aug; 30(8):828-31. PubMed ID: 7119425
    [No Abstract]   [Full Text] [Related]  

  • 15. N1-methyl-2-[125I]LSD ([125I]MIL), a preferred ligand for serotonin 5-HT2 receptors.
    Hoffman BJ; Karpa MD; Lever JR; Hartig PR
    Eur J Pharmacol; 1985 Mar; 110(1):147-8. PubMed ID: 4007051
    [No Abstract]   [Full Text] [Related]  

  • 16. The actions of neuroleptic drugs and putative serotonin receptor antagonists on LSD and quipazine-induced reductions of brain 5-HIAA concentrations.
    Jacoby JH; Poulakos JJ
    J Pharm Pharmacol; 1977 Dec; 29(12):771-3. PubMed ID: 22629
    [No Abstract]   [Full Text] [Related]  

  • 17. Serotonin receptors in the brain.
    Haigler HJ; Aghajanian GK
    Fed Proc; 1977 Jul; 36(8):2159-64. PubMed ID: 326580
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of lysergic acid diethylamide on the metabolism of brain 5-hydroxytryptamine.
    Rosecrans JA; Lovell RA; Freedman DX
    Biochem Pharmacol; 1967 Oct; 16(10):2011-21. PubMed ID: 6065966
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo receptor binding: attempts to improve specific/non-specific ratios.
    Niehoff DL; Palacios JM; Kuhar MJ
    Life Sci; 1979 Sep; 25(10):819-26. PubMed ID: 491833
    [No Abstract]   [Full Text] [Related]  

  • 20. Ergolines as selective 5-HT1 agonists.
    Ward JS; Fuller RW; Merritt L; Snoddy HD; Paschal JW; Mason NR; Horng JS
    J Med Chem; 1988 Aug; 31(8):1512-9. PubMed ID: 2456389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.